Concepedia

Kaori Yuki

KY

Statistics

Publications

4

Citations

319

H-Index

4

Active since

2013

Affiliations

Chiba University(Current)

King's College Hospital

Kaori Yuki is an author at Chiba University specializing in oncology, medicine, and molecular oncology.

Publications per year

2013–2017

4

Publications

4

Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma

Tetsuhiro Chiba, Tomoko Saito, Kaori Yuki et al. · International Journal of Cancer · 2014 · 118 citations · Full text

, , +17

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners

Tetsuhiro Chiba, Eiichiro Suzuki, Kaori Yuki et al. · PLoS ONE · 2014 · 79 citations · Full text

, , +17

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells

Tomoko Saito, Tetsuhiro Chiba, Kaori Yuki et al. · PLoS ONE · 2013 · 75 citations · Full text

, , +15

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma

Masayuki Yokoyama, Tetsuhiro Chiba, Yoh Zen et al. · Oncotarget · 2017 · 47 citations · Full text

, , +16

1–4 of 4